We are live on ! Find out more
TA

Teachers Advisors Portfolio holdings

AUM $81.7B
1-Year Est. Return 13.62%
This Fund
S&P 500
This Quarter Est. Return
-13.12%
1 Year Est. Return
+13.62%
3 Year Est. Return
+67.19%
5 Year Est. Return
+103.94%
10 Year Est. Return
–
AUM
$71.1B
AUM Growth
-$11.9B
Cap. Flow
+$774M
Cap. Flow %
1.09%
Top 10 Hldgs %
14.89%
Holding
3,088
New
67
Increased
1,601
Reduced
741
Closed
83

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$289M
2
JPM icon
JPMorgan Chase
JPM
+$196M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$163M
4
JNJ icon
Johnson & Johnson
JNJ
+$160M
5
CI icon
Cigna
CI
+$145M

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$178M
2
AGN
Allergan plc
AGN
+$129M
3
AET
Aetna Inc
AET
+$126M
4
KHC icon
Kraft Heinz
KHC
+$96M
5
ESRX
Express Scripts Holding Company
ESRX
+$83.8M

Sector Composition

Rank Sector Weight
1 Technology 17.25%
2 Financials 15.31%
3 Healthcare 14.25%
4 Consumer Discretionary 10.15%
5 Industrials 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNA
2951
DELISTED
Allena Pharmaceuticals
ALNA
$77K ﹤0.01%
14,146
– –
NEOS
2952
DELISTED
Neos Therapeutics, Inc
NEOS
$73K ﹤0.01%
44,002
– –
IMH
2953
DELISTED
Impac Mortgage Holdings Inc.
IMH
$73K ﹤0.01%
19,205
– –
WFT
2954
DELISTED
Weatherford International plc
WFT
$71K ﹤0.01%
127,822
-10,542,205
-99% -$13.8M
CTIC
2955
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$71K ﹤0.01%
96,473
– –
IMDZ
2956
DELISTED
Immune Design Corp.
IMDZ
$68K ﹤0.01%
52,279
– –
IBRX icon
2957
ImmunityBio
IBRX
$7.32B
$64K ﹤0.01%
55,383
– –
NL icon
2958
NLI Holdings
NL
$283M
$64K ﹤0.01%
18,356
– –
CLSD
2959
DELISTED
Clearside Biomedical
CLSD
$62K ﹤0.01%
3,874
+576
+17% +$27K
FCEL icon
2960
FuelCell Energy
FCEL
$1.72B
$61K ﹤0.01%
307
– –
RMNI icon
2961
Rimini Street
RMNI
$432M
$61K ﹤0.01%
11,929
– –
MBIO icon
2962
Mustang Bio
MBIO
$4.24M
$60K ﹤0.01%
27
– –
ZOM
2963
DELISTED
Zomedica Corp.
ZOM
$59K ﹤0.01%
48,150
– –
ADMA icon
2964
ADMA Biologics
ADMA
$1.97B
$55K ﹤0.01%
23,078
– –
SER icon
2965
Serina Therapeutics
SER
$31.5M
$55K ﹤0.01%
+527
New +$67K
NMTR
2966
DELISTED
9 Meters Biopharma
NMTR
$54K ﹤0.01%
1,164
– –
KEG
2967
DELISTED
Key Energy Services, Inc. Common Stock
KEG
$54K ﹤0.01%
26,236
-4,614
-15% -$33.7K
VYNE icon
2968
VYNE Therapeutics
VYNE
$19.1M
$51K ﹤0.01%
3
– –
SNNA
2969
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$49K ﹤0.01%
20,992
– –
PFIE
2970
DELISTED
Profire Energy, Inc
PFIE
$46K ﹤0.01%
32,046
– –
MTEM
2971
DELISTED
Molecular Templates, Inc.
MTEM
$45K ﹤0.01%
735
– –
AMPE
2972
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$41K ﹤0.01%
344
– –
OVID icon
2973
Ovid Therapeutics
OVID
$439M
$39K ﹤0.01%
16,253
– –
VERI icon
2974
Veritone
VERI
$100M
$39K ﹤0.01%
10,280
– –
PHIIK
2975
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$35K ﹤0.01%
18,834
-5,206
-22% -$30.1K
117 118
119
120 121

Similar funds

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
SBAM
Santa Barbara Asset Management Los Angeles, California $6.43B AUM 10.99% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
SA
SQ Advisors Naples, Florida $1.32B AUM 10.3% 1-Year Est. Return
WF
WealthTrust Fairport Cleveland, Ohio $1.06B AUM 3.47% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Teachers Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Teachers Advisors held 3,088 positions worth $71.1B, down 14% from $83B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 4.9%. Teachers Advisors opened 67 new positions and exited 83, leaving the 3,088-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • Teachers Advisors's largest Q4 2018 buy was Linde: 1,830,984 shares worth $286M.
  • Teachers Advisors added most to JPMorgan Chase in Q4 2018, an estimated $196M increase.
  • Teachers Advisors's biggest Q4 2018 reduction was Allergan plc, cutting an estimated $129M.
  • Teachers Advisors fully exited Praxair Inc in Q4 2018, selling an estimated $178M.
  • Teachers Advisors's ten largest holdings make up 15% of its $71.1B portfolio in Q4 2018.
  • Teachers Advisors opened 67 new positions and closed 83 in Q4 2018.
  • Teachers Advisors's portfolio value fell 14% quarter-over-quarter to $71.1B.

Based on Teachers Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.